Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane, Carboplatin, and Trastuzumab in HER2+ Breast Cancer
NCT00617942Phase 2Completed
- Start
- Feb 2008
- Primary completion
- Aug 2012
- Modality
- Polymer-based Nanoparticles, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label trial of nab-paclitaxel, carboplatin and trastuzumab in breast cancer. Started Feb 2008; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00617942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00617942.